We are pleased to invite you to read the most viewed papers in 2023 in Cancers (ISSN: 2072-6694) on the topic of pediatric oncology. The list of papers is as follows:

“Pediatric Myeloid Sarcoma, More than Just a Chloroma: A Review of Clinical Presentations, Significance, and Biology”
by Kristin E. Zorn, Ashley M. Cunningham, Alison E. Meyer, Karen Sue Carlson and Sridhar Rao
Cancers 2023, 15(5), 1443; https://doi.org/10.3390/cancers15051443
Available online: https://www.mdpi.com/2072-6694/15/5/1443

“Synovial Sarcoma Preclinical Modeling: Integrating Transgenic Mouse Models and Patient-Derived Models for Translational Research”
by Lorena Landuzzi, Francesca Ruzzi, Pier-Luigi Lollini and Katia Scotlandi
Cancers 2023, 15(3), 588; https://doi.org/10.3390/cancers15030588
Available online: https://www.mdpi.com/2072-6694/15/3/588

“Repurposing Atovaquone as a Therapeutic against Acute Myeloid Leukemia (AML): Combination with Conventional Chemotherapy Is Feasible and Well Tolerated”
by Alexandra McLean Stevens, Eric S. Schafer, Minhua Li, Maci Terrell, Raushan Rashid, Hana Paek, Melanie B. Bernhardt, Allison Weisnicht, Wesley T. Smith, Noah J. Keogh et al.
Cancers 2023, 15(4), 1344; https://doi.org/10.3390/cancers15041344
Available online: https://www.mdpi.com/2072-6694/15/4/1344

“Biological Role and Clinical Implications of MYOD1^L122R Mutation in Rhabdomyosarcoma”
by Daniela Di Carlo, Julia Chisholm, Anna Kelsey, Rita Alaggio, Gianni Bisogno, Veronique Minard-Colin, Meriel Jenney, Raquel Dávila Fajardo, Johannes H. M. Merks, Janet M. Shipley et al.
Cancers 2023, 15(6), 1644; https://doi.org/10.3390/cancers15061644
Available online: https://www.mdpi.com/2072-6694/15/6/1644

“Adapting the Voicing My CHOiCES Advance Care Planning Communication Guide for Australian Adolescents and Young Adults with Cancer: Appropriateness, Acceptability, and Considerations for Clinical Practice”
by Ursula M. Sansom-Daly, Megan Zhang, Holly E. Evans, Jordana McLoone, Lori Wiener, Richard J. Cohn, Antoinette Anazodo, Pandora Patterson and Claire E. Wakefield
Cancers 2023, 15(7), 2129; https://doi.org/10.3390/cancers15072129
Available online: https://www.mdpi.com/2072-6694/15/7/2129

“Drug Resistance in Medulloblastoma Is Driven by YB-1, ABCB1 and a Seven-Gene Drug Signature”
by Louisa Taylor, Philippa K. Wade, James E. C. Johnson, Macha Aldighieri, Sonia Morlando, Gianpiero Di Leva, Ian D. Kerr and Beth Coyle
Cancers 2023, 15(4), 1086; https://doi.org/10.3390/cancers15041086
Available online: https://www.mdpi.com/2072-6694/15/4/1086

“Immune Microenvironment and Immunotherapies for Diffuse Intrinsic Pontine Glioma”
by Yujia Chen, Chao Zhao, Shenglun Li, Jun Wang and Hongwei Zhang
Cancers 2023, 15(3), 602; https://doi.org/10.3390/cancers15030602
Available online: https://www.mdpi.com/2072-6694/15/3/602

“Genomic and Epigenetic Changes Drive Aberrant Skeletal Muscle Differentiation in Rhabdomyosarcoma”
by Silvia Pomella, Sara G. Danielli, Rita Alaggio, Willemijn B. Breunis, Ebrahem Hamed, Joanna Selfe, Marco Wachtel, Zoe S. Walters, Beat W. Schäfer, Rossella Rota et al.
Cancers 2023, 15(10), 2823; https://doi.org/10.3390/cancers15102823
Available online: https://www.mdpi.com/2072-6694/15/10/2823

“Advancing Pediatric Oncology Rehabilitation: Survey Findings of Health Professionals’ Perceptions of Barriers to Care and a Framework for Action”
by Paula A. Ospina, Lesley Pritchard, David D. Eisenstat and Margaret L. McNeely
Cancers 2023, 15(3), 693; https://doi.org/10.3390/cancers15030693
Available online: https://www.mdpi.com/2072-6694/15/3/693

“Venetoclax for Acute Myeloid Leukemia in Pediatric Patients: A Texas Medical Center Experience”
by Adriana Trabal, Amber Gibson, Jiasen He, David McCall, Michael Roth, Cesar Nuñez, Miriam Garcia, Meredith Buzbee, Laurie Toepfer, Aram Bidikian et al.
Cancers 2023, 15(7), 1983; https://doi.org/10.3390/cancers15071983
Available online: https://www.mdpi.com/2072-6694/15/7/1983

You are welcome to submit relevant papers to the journal Cancers. If you have any questions, you can contact the Editorial Office via cancers@mdpi.com.

Cancers Editorial Office